Advanced Biomed Inc Increase Decrease In Operating Lease Liability
Advanced Biomed Inc (ADVB) reported Increase Decrease In Operating Lease Liability of -$1.04 thousand for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-05-15
- Advanced Biomed Inc increase decrease in operating lease liability for the quarter ending 2025-09-30 was $11.78K, a 364.55% increase year-over-year.
- Advanced Biomed Inc increase decrease in operating lease liability for the quarter ending 2025-06-30 was -$25.69K.
- Advanced Biomed Inc increase decrease in operating lease liability for the quarter ending 2025-03-31 was -$246.00.
- Advanced Biomed Inc increase decrease in operating lease liability for the quarter ending 2024-12-31 was -$312.00.
- Advanced Biomed Inc increase decrease in operating lease liability for fiscal 2025 was -$23.71K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 6 month as first filed | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | -$1.04K 10-Q · filed 2026-05-15 | ||||
| 2025-09-30 | $11.78K 10-Q · filed 2025-11-19 | -$13.91K derived: sum of 2 quarters · filed 2025-11-19 | -$14.15K derived: sum of 3 quarters · filed 2026-05-15 | -$14.46K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2025-06-30 | -$25.69K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-08 | -$25.93K derived: sum of 2 quarters · filed 2026-05-15 | -$26.25K derived: sum of 3 quarters · filed 2026-05-15 | -$23.71K 10-K · filed 2025-10-08 | |
| 2025-03-31 | -$246.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-15 | -$558.00 derived: sum of 2 quarters · filed 2026-05-15 | $1.98K 10-Q · filed 2026-05-15 | ||
| 2024-12-31 | -$312.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-13 | $2.22K 10-Q · filed 2026-02-13 | $48.76K 10-Q · filed 2025-04-15 | ||
| 2024-09-30 | $2.54K 10-Q · filed 2025-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |